Connect your AI

Pfizer PFE Derivative, Net Liability Position, Aggregate Fair Value

Derivative, Net Liability Position, Aggregate Fair Value at other companies

Apollo Global ManagementAPO

$543M+198%

EFC

Ellington Financial Inc.EFC

$607K0.0%

M&T BankMTB

$1.38B—

KKR & Co.KKR

$1.15B+71.1%

Apollo Global ManagementAPO

$5.43B+96.3%

OvintivOVV

$241M+424%

Other financials

Income statement

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+5.0%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

Market cap$143.68B+11.1%

Enterprise value$206.35B+9.2%

P/E11.9×—

P/S2.3×+0.2×

Profitability

Gross margin73.5%+1.2pp

Net margin15.7%—

Returns & leverage

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:DerivativeNetLiabilityPositionAggregateFairValue.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's derivative, net liability position, aggregate fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pfizer's derivative, net liability position, aggregate fair value?: Pfizer (PFE) reported derivative, net liability position, aggregate fair value of $1.1B in Q1 2026.
How has Pfizer's derivative, net liability position, aggregate fair value changed year-over-year?: Pfizer's derivative, net liability position, aggregate fair value increased by 70.3% year-over-year, from $646M to $1.1B.